Elan repays $450m debt
Elan has announced the repayment by Elan Pharmaceutical Investments II, Ltd. (EPIL II) of a $450m (€370m) debt which fell for payment yesterday.
Accrued interest on the debt for the period from December 31, 2003 to June 28, 2004 amounted to $21.5m (€17.7m).
CONNECT WITH US TODAY
Be the first to know the latest news and updates